[Federal Register Volume 78, Number 97 (Monday, May 20, 2013)]
[Notices]
[Page 29390]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-11933]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Proj-0792; NRC-2013-0053]


Applications; SHINE Medical Technologies, Inc.

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice; receipt and availability.

-----------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT: Steven Lynch, Project Manager, Office 
of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001; telephone: 301-415-1524; email: 
[email protected].

SUPPLEMENTARY INFORMATION: On March 26, 2013 (SMT-2013-012, Agencywide 
Documents Access and Management System (ADAMS) Accession No. 
ML13088A192), SHINE Medical Technologies (SHINE) filed with the U.S. 
Nuclear Regulatory Commission (NRC) pursuant to Section 103 of the 
Atomic Energy Act, and Part 50 of Title 10 of the Code of Federal 
Regulations (10 CFR), a portion of an application for a construction 
permit application for a medical radioisotope production facility in 
Janesville, Wisconsin.
    An exemption from certain requirements of 10 CFR 2.101(a)(5) 
granted by the Commission on March 20, 2013 (ADAMS Accession No. 
ML13072B195), in response to a letter from SHINE dated February 18, 
2013 (ADAMS Accession No. ML13051A007), allowed for SHINE to submit its 
construction permit application in two parts. Specifically, the 
exemption allowed SHINE to submit a portion of its application for a 
construction permit up to six months prior to the remainder of the 
application regardless of whether or not an environmental impact 
statement or a supplement to an environmental impact statement is 
prepared during the review of its application. On March 26, 2013, in 
accordance with 10 CFR 2.101(a)(5), SHINE submitted the following in 
part one of the construction permit application:

 the description and safety assessment of the site required by 
10 CFR 50.34(a)(1)
 the environmental report required by 10 CFR 50.30(f)
 the filing fee information required by 10 CFR 50.30(e) and 10 
CFR 170.21
 the general information required by 10 CFR 50.33
 the agreement limiting access to classified information 
required by 10 CFR 50.37

    As stated in SHINE's March 26, 2013, letter, part two of SHINE's 
application for a construction permit will contain the remainder of the 
preliminary safety analysis report required by 10 CFR 50.34(a) and will 
be submitted in accordance with the requirements of 10 CFR 2.101(a)(5).
    Subsequent Federal Register notices will address the acceptability 
of this part of the tendered construction permit application for 
docketing and provisions for public participation in the construction 
permit application review process.
    A copy of the application is available for public inspection at the 
NRC's Public Document Room (PDR), located at One White Flint North, 
11555 Rockville Pike (first floor), Rockville, Maryland 20852. Publicly 
available documents created or received at the NRC are available online 
in the NRC Library at http://www.nrc.gov/reading-rm/adams.html. The 
accession number for the application is ML130880226. Future publicly 
available documents related to the application will also be posted in 
ADAMS. Persons who do not have access to ADAMS or who encounter 
problems in accessing the documents located in ADAMS should contact the 
NRC Public Document Room staff by telephone at 1-800-397-4209 or 301-
415-4737, or by email to [email protected].


    Dated at Rockville, Maryland, this 8th day of May, 2013.

    For the Nuclear Regulatory Commission.
Alexander Adams, Jr.,
Chief, Research and Test Reactors Licensing Branch, Division of Policy 
and Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2013-11933 Filed 5-17-13; 8:45 am]
BILLING CODE 7590-01-P